Synapse - Matthew Milowsky

Search Within

Matthew I Milowsky

Results (76)

Phase II trial of gemcitabine, carboplatin, and bevacizumab (Bev) in patients (pts) with advanced/metastatic urothelial carcinoma (UC)

Meeting Abstract

Balar, A. V.; Milowsky, M. I.; Apolo, A. B.; Ostrovnaya, I.; Iasonos, A.; Trout, A.; Regazzi, A. M.; Garcia-Grossman, I. R.; Gallagher, D. J.; Bajorin, D. F.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

NCI 6896: A phase I trial of suberoylanilide hydroxamic acid (SAHA) and 13-cis retinoic acid in the treatment of patients with advanced renal cell carcinoma (RCC)

Meeting Abstract

Nanus, D. M.; Tagawa, S. T.; Dutcher, J. P.; Akhtar, N. H.; Saran, A.; Mazumdar, M.; Milowsky, M. I.; Gudas, L. J.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium

Meeting Abstract

Milowsky, M. I.; Regazzi, A. M.; Garcia-Grossman, I. R.; Trout, A.; Flaherty, A.; Gerst, S.; Bajorin, D. F.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Phase II trial of gemcitabine, carboplatin, and bevacizumab in chemotherapy-naive patients (Pts) with advanced/metastatic urothelial carcinoma (UC)

Meeting Abstract

Balar, A. V.; Milowsky, M. I.; Apolo, A. B.; Ostrovnaya, I.; Iasonos, A.; Trout, A.; Regazzi, A. M.; Garcia-Grossman, I. R.; Gallagher, D. J.; Bajorin, D. F.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Germline single-nucleotide polymorphisms (SNPs) associated with response of urothelial carcinoma (UC) to platinum-based therapy: The role of the host

Meeting Abstract

Gallagher, D.; Joseph, V.; Garcia-Grossman, I. R.; Przybylo, J. A.; Riches, J. C.; Ostrovnaya, I.; Hamilton, R.; Milowsky, M. I.; Offit, K.; Bajorin, D. F.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Alterations in genes regulating cell cycle and apoptosis in high-grade urothelial carcinoma

Meeting Abstract

Al-Ahmadie, H.; Iyer, G.; Lin, O.; Gopalan, A.; Fine, S.; Tickoo, S.; Reuter, V. E.; Bajorin, D. F.; Milowsky, M. I.; Solit, D. B.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Genomic analysis of high grade bladder cancer: Defining genetic subtypes and therapeutic targets

Meeting Abstract

Iyer, G.; Al-Ahmadie, H.; Taylor, B. S.; Janakiraman, M.; Lin, O.; Socci, N. D.; Heguy, A.; Viale, A.; Bochner, B.; Bajorin, D.; more...
Cancer Research (2011)

Fulltext@MSK | Save

Chemotherapy for metastatic bladder cancer, alone or in combination with other treatment

Book Section

Milowsky, M. I.; Bajorin, D. F.
In Scardino, P. T.; Linehan, W. M.; Zelefsky, M. J.; Vogelzang, N. J.; Sheinfeld, J.; Rini, B. I.; Bochner, B. H. (Eds.) Comprehensive Textbook of Genitourinary Oncology. 4th ed (2011)

Fulltext@MSK | Save

Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy

Journal Article

Kaag, M. G.; Milowsky, M. I.; Dalbagni, G.; Thompson, R. H.; Katz, D.; Reuter, V. E.; Herr, H. W.; Bajorin, D.; Bochner, B. H.
BJU International (2011)

Fulltext@MSK | Save

A phase i trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York cancer consortium trial NCI 6981

Journal Article

Tagawa, S. T.; Milowsky, M. I.; Jeske, S.; Mazumdar, M.; Kung, S.; Sung, M.; Lehrer, D.; Matulich, D.; Selzer, J.; Wright, J. J.; more...
American Journal of Clinical Oncology (2011)

Fulltext@MSK | Save